Riskpilot← Back to searchSign inGet full accessEwimed Sweden AB
ABActiveOrg 5566908207Adelgatan 21Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200513 employees
Revenue 2024
SEK 36,7M
+6% vs 2023
EBITDA margin
-1.0%
-122% vs 2023
Equity ratio
60.9%
Financial strength
Net profit 2024
SEK -116K
-109% vs 2023
| Revenue | SEK 36,7M | +6% |
| EBITDA | SEK -377K | -122% |
| Net profit | SEK -116K | -109% |
| Total assets | SEK 17,1M | +3% |
| Equity | SEK 10,4M | -1% |
| Employees | 13 | — |
Legal name
Ewimed Sweden AB
Org number
5566908207
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
21 november 2005
Share capital
SEK 100 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva utveckling, produktion och försäljning av medicinsk utrustning, och att därtill äga och förvalta värdepapper, fast och lös egendom, samt idka därmed förenlig verksamhet.
Address
Adelgatan 21
Phone
+468251169
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 25 322 | 30 457 | 33 403 | 34 534 | 36 667 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 128 | 3 356 | 3 003 | 1 680 | −377 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 128 | 3 356 | 3 003 | 1 680 | −377 |
| Net financials | — | — | −27 | −24 | 318 |
| Profit before tax | 1 128 | 3 357 | 2 976 | 1 656 | −59 |
| Tax | −0 | −169 | −645 | −383 | −57 |
| Net profit | 1 128 | 3 188 | 2 331 | 1 273 | −116 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 493 | 15 060 | 17 127 | 16 663 | 17 116 |
| Equity | 3 740 | 6 928 | 9 259 | 10 532 | 10 416 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 753 | 8 132 | 7 868 | 6 131 | 6 700 |
| Total debt | 6 753 | 8 132 | 7 868 | 6 131 | 6 700 |
EBITDA margin
-1.0%
This company
15.8%
Market median
-106% vs market
20202024
Equity ratio
60.9%
This company
38.2%
Market median
+59% vs market
20202024
Return on equity
-1.1%
This company
18.4%
Market median
-106% vs market
20202024
Net profit margin
-0.3%
This company
8.1%
Market median
-104% vs market
20202024
Asset turnover
2.14×
This company
1.12×
Market median
+91% vs market
20202024
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ML | Audit | 2021 |
NE Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
JP Chief Executive Officer | Chief Executive Officer | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ankron Holding AB
Ewimed Sweden AB Board members of Ewimed Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats-Åke Lennart Andersson | Audit | 0 companies |
| Niklas Erik Wiest | Chief Executive Officer | 0 companies |
| Jan Peter Tomas Jalrup | Chief Executive Officer | 0 companies |
| Egon Edgar Wiest | Chairman | 0 companies |
| Maria Ann-Charlotte Wiest | Board of Directors | 0 companies |
| Marie Ann-Charlotte Wiest | Board of Directors | 0 companies |
| Felix Nils Wiest | Deputy Board Member | 0 companies |